首页|血清GFAP、MMP-9检测对高血压脑出血患者神经功能损伤程度的预测价值

血清GFAP、MMP-9检测对高血压脑出血患者神经功能损伤程度的预测价值

扫码查看
[目的]探讨高血压脑出血(HICH)患者胶质纤维酸性蛋白(GFAP)、基质金属蛋白酶-9(MMP-9)与神经功能损伤程度的关系.[方法]102 例 HICH 患者和 85 例未发生脑出血的高血压患者,分别记为HICH 组、高血压组,另选取 80 例体检健康者,设为健康组,比较三组 GFAP、MMP-9 水平.采用美国国立卫生研究院卒中量表(NIHSS)评估 HICH 患者神经功能损伤程度,并据此分为轻度组、中度组和重度组.对比不同神经功能缺损程度 HICH 患者的 GFAP、MMP-9 水平.采用 Pearson 相关性分析 HICH 患者 GFAP、MMP-9 水平与神经功能损伤程度的相关性.随访 6 个月,依据格拉斯哥预后评分(GOS)评估 HICH 患者预后情况,比较预后良好组和预后不良组患者 GFAP、MMP-9 水平.制作受试者工作特征(ROC)曲线,以曲线下面积(AUC)分析 GFAP、MMP-9 及两者联合对 HICH 患者预后的预测价值.[结果]高血压组和 HICH 组患者 GFAP、MMP-9 水平高于健康组(P<0.05);HICH 组患者血清 GFAP、MMP-9 水平高于高血压组(P<0.05).中度组和重度组患者 GFAP、MMP-9 水平高于轻度组(P<0.05);重度组患者 GFAP、MMP-9 水平高于中度组(P<0.05).HICH 患者 GFAP、MMP-9 与神经功能损伤程度呈正相关(P<0.05).预后不良组 GFAP、MMP-9 水平高于预后良好组(P<0.05).ROC 曲线结果显示,GFAP、MMP-9 及两者联合对HICH 患者预后预测的 AUC分别为 0.978、0.884 和 0.925,GFAP 对 HICH 患者预后的预测价值最高.[结论]血清 GFAP、MMP-9 水平与 HICH 患者神经功能损伤程度、预后有关,且对患者预后的预测效能较高.
The Predictive Value of Serum GFAP and MMP-9 Detection for Neurological Damage in Patients with Hypertensive Intracerebral Hemorrhage
[Objective]To explore the relationship between glial fibrillary acidic protein(GFAP),matrix metalloproteinase-9(MMP-9)and the degree of neurological damage in patients with hypertensive intracere-bral hemorrhage(HICH).[Methods]A total of 102 HICH patients and 85 hypertensive patients without cere-bral hemorrhage were recorded as HICH group and hypertensive group,respectively.Another 80 healthy indi-viduals who underwent physical examination were selected as the health group.Three groups of GFAP and MMP-9 levels were compared;The National Institutes of Health Stroke Scale(NIHSS)was used to evaluate the degree of neurological damage in HICH patients,and based on this,they were divided into mild,moder-ate,and severe groups.We compared the levels of GFAP and MMP-9 in HICH patients with different degrees of neurological deficits.Pearson correlation analysis was used to investigate the correlation between GFAP,MMP-9 levels and the degree of neurological damage in HICH patients.After a 6-month follow-up,the prog-nosis of HICH patients was evaluated based on the Glasgow Outcome Scale(GOS),and the levels of GFAP and MMP-9 were compared between the group with good prognosis and the group with poor prognosis.A re-ceiver operating characteristic curve(ROC)was created to analyze the predictive value of GFAP,MMP-9,and their combination on the prognosis of HICH patients using area under the curve(AUC).[Results]The levels of GFAP and MMP-9 in patients with hypertension and HICH were higher than those in the healthy group(P<0.05);The levels of GFAP and MMP-9 in the HICH group were higher than those in the hypertension group(P<0.05).The levels of GFAP and MMP-9 in patients in the moderate and severe groups were higher than those in the mild group(P<0.05);The levels of GFAP and MMP-9 in the severe group were higher than those in the moderate group(P<0.05).The levels of GFAP and MMP-9 in HICH patients are positively cor-related with the degree of neurological damage(P<0.05).The levels of GFAP and MMP-9 in the poor prog-nosis group were higher than those in the good prognosis group(P<0.05).The ROC results showed that the AUC of GFAP,MMP-9,and their combination for predicting the prognosis of HICH patients were 0.978,0.884,and 0.925,respectively.GFAP had the highest predictive value for the prognosis of HICH patients.[Conclusion]Serum levels of GFAP and MMP-9 are related to the degree of neurological damage and prognosis in HICH patients,and have a high predictive power for patient prognosis.

Intracranial Hemorrhage,HypertensiveGlial Fibrillary Acidic Protein/BLMatrix Metalloproteinase 9/BL

黄利娜、李相磊、张海军

展开 >

开封市中心医院 检验科,河南 开封 475000

开封市中心医院 神经外科,河南 开封 475000

颅内出血,高血压性 神经胶质原纤维酸性蛋白质/血液 基质金属蛋白酶9/血液

2024

医学临床研究
湖南省医学会

医学临床研究

影响因子:0.595
ISSN:1671-7171
年,卷(期):2024.41(2)
  • 12